Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

291 Views

Session: Infections in Transplant and Hematologic Malignancy Patients, Part 1

162 - Comparison of Clinical Risk Factors, Outcomes and Molecular Epidemiology of ESBL and non-ESBL Enterobacterales Bacteremia in Solid Organ Transplant Recipients

Thursday, October 17, 2024

2:30 PM – 2:45 PM US PT

Location: 408 A

Presenting Author(s)

Navina K. Birk, MD

Fellow In Training
Henry Ford Hospital
Detroit, Michigan, United States
GA

George J. Alangaden, M.D.

Infectious Diseases Transplant Fellowship, Program Director
Henry Ford Health
Detroit, Michigan, United States
GS

Geehan Suleyman, MD (she/her/hers)

Medical Director, Infection Prevention
Henry Ford Health
Detroit, Michigan, United States
Jagjeet Kaur, PhD (she/her/hers)

Research Scientist
Henry Ford Health
Detroit, Michigan, United States
MR

Mayur Ramesh, MD

Senior Staff Physician, Infectious Diseases
Henry Ford Hospital
Detroit, MI, United States

Disclosure(s):

Zachary W. Hanna, DO: No financial relationships to disclose

Navina K. Birk, MD: No financial relationships to disclose

George J. Alangaden, M.D.: No financial relationships to disclose

Geehan Suleyman, MD: No financial relationships to disclose

Jagjeet Kaur, PhD: No financial relationships to disclose

Mayur Ramesh, MD: AstraZeneca: Advisor/Consultant; Moderna: Advisor/Consultant; Pfizer: Advisor/Consultant